Clinical Benefits of an Adherence Monitoring Program in the Management of Secondary Hyperparathyroidism with Cinacalcet: Results of a Prospective Randomized Controlled Study

Background/Aims. One of the causes of uncontrolled secondary hyperparathyroidism (sHPT) is patient's poor drug adherence. We evaluated the clinical benefits of an integrated care approach on the control of sHPT by cinacalcet. Methods. Prospective, randomized, controlled, multicenter, open-label...

Descripción completa

Detalles Bibliográficos
Autores principales: Forni Ogna, Valentina, Pruijm, Menno, Zweiacker, Carole, Wuerzner, Grégoire, Tousset, Eric, Burnier, Michel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3732637/
https://www.ncbi.nlm.nih.gov/pubmed/23971019
http://dx.doi.org/10.1155/2013/104892

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3732637/
https://www.ncbi.nlm.nih.gov/pubmed/23971019
http://dx.doi.org/10.1155/2013/104892

Ejemplares similares